Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paolo Gisondi and Giampiero Girolomoni.
Paolo Gisondi
Connection Strength
2.308
Giampiero Girolomoni
  1. The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments. Vaccines (Basel). 2020 Dec 02; 8(4).
    View in: PubMed
    Score: 0.916
  2. Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment. J Am Acad Dermatol. 2020 Jul; 83(1):285-287.
    View in: PubMed
    Score: 0.878
  3. The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1099-1107.
    View in: PubMed
    Score: 0.232
  4. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update. J Eur Acad Dermatol Venereol. 2020 Nov; 34(11):2499-2504.
    View in: PubMed
    Score: 0.223
  5. Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? J Eur Acad Dermatol Venereol. 2021 Jun; 35(6):e355-e357.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.